| Website | affinitycapitalma... |
| Phone | 612-252-9900 |
| Employees | |
| Founded | 1993 |
| Description | Healthy Outcomes. Healthy Returns. |
Affinity Capital Management works with innovative and visionary companies and entrepreneurs to create groundbreaking improvements in health care. From exciting new devices and treatments, to improved and cost effective care, to more efficient and affordable technology systems, Affinity helps to create extraordinary value in health care. In doing so, they are proud of the significant impact their portfolio companies have on people’s lives.
| Company | Date | Round | Size | Participants |
| Uptake Medical | 2/12 | Series C | $35M | 7 |
| Uptake Medical | 7/10 | Series B | $17.5M | 6 |
| Baxano | 6/10 | Series C | $30M | 6 |
| Anulex | 6/10 | Series E | $18.3M | 4 |
| Hemosphere | 4/10 | Series A | $9.3M | 6 |
| ValenTx | 10/09 | Series B | $20.3M | 6 |
| CoAxia | 6/09 | Series D | $21.5M | 6 |
| iScience Interventional | 5/09 | Series F | $20.5M | 8 |
| Primaeva Medical | 2/09 | Series C | $6M | 3 |
| Cardiac Concepts | 10/08 | Series B | $21M | 6 |
| NovaSys | 5/08 | Venture Round | $49.5M | 10 |
| Anulex | 7/06 | Series C | $20M | 6 |